Actively Recruiting
Assessment of Brain Cognitive Impairment in Breast Cancer
Led by Tang-Du Hospital · Updated on 2022-07-13
90
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
Sponsors
T
Tang-Du Hospital
Lead Sponsor
X
Xi'an Jiaotong University
Collaborating Sponsor
AI-Summary
What this Trial Is About
To explore the cognitive impairment caused by chemotherapy and endocrine therapy in premenopausal breast cancer patients and to find biomarkers with early predictive effect on this cognitive impairment by using multimodal integrated PET/MRI technology combined with psychobehavioral technology.
CONDITIONS
Official Title
Assessment of Brain Cognitive Impairment in Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with primary stage I-II breast cancer.
- Premenopausal women based on National Comprehensive Cancer Network Breast Cancer Guidelines.
- No treatment other than surgery has started (if neoadjuvant chemotherapy is needed, enrollment before chemotherapy starts).
- Eastern Cooperative Oncology Group score of 0-1 points.
- Ability to understand and complete various scales.
- Right-handed.
- Female subjects of childbearing potential must use medically-approved contraception during the study.
- Signed informed consent and voluntary participation in the clinical observation.
You will not qualify if you...
- Central nervous system disease, history of malignancy, chronic loss of consciousness, head trauma, or any disease affecting cognitive function.
- Current or former epilepsy, dementia, or learning disabilities.
- Past psychiatric history.
- Past history of malignancy.
- MRI contraindications such as pacemakers, defibrillators, hearing aids, insulin pumps, drug dose control devices, or other metal implants.
- Severe hyperthermia.
- Claustrophobia.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tangdu Hospital
Xi'an, Shaanxi, China, 710038
Actively Recruiting
Research Team
M
Menghui Yuan, phd
CONTACT
L
Lijun Bai, phd
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here